A prospective study of salvage high-intensity focused ultrasound for locally radiorecurrent prostate cancer: Early results

Scandinavian Journal of Urology and Nephrology

Volumn 44, Issue 4, 2010, Pages 223-227

  Berge, Viktor ^a   Baco, Eduard ^a   Karlsen, Steinar Johan ^a,b  

^a AKER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

HIFU; Prostate cancer; Salvage treatment

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FOLLOW UP; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; RECURRENT CANCER; SALVAGE THERAPY; URETHRA FISTULA; URETHROCUTANEOUS FISTULA; URETHRORECTAL FISTULA;

AGED; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT FAILURE; TREATMENT OUTCOME; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 77955526493     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.3109/00365591003727551     Document Type: Article

References (15)

1. Kuban DA, Thames HD, Levy LB, Horwitz EM, Kupelian PA, Martinez AA, et al. Long-term multiinstitutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys 2003;57:915-928
2. Crook J, Malone S, Perry G, Bahadur Y, Robertson S, Abdolell M. Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients. Int J Radiat Oncol Biol Phys 2000;48:355-367
3. Pollack A, Zagars GK, Antolak JA, Kukan DA, Rosen II. Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial. Int J Radiat Oncol Biol Phys 2002;54:677-685
4. Coen JJ, Zietman AL, Thakral H, Shipley WU. Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastases. J Clin Oncol 2002;20:3199-3205
5. Touma NJ, Izawa JI, Chin JL. Current status of local salvage therapies following radiation failure for prostate cancer. J Urol 2005;173:373-379
6. Rukstalis DB. Treatment options after failure of radiation therapy - a review. Rev Urol 2002;4:S12-7.
7. Murat F-J, Poissonnier L, Rabilloud M, Belot A, Bouvier R, Olivier R, et al. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer. Eur Urol 2009;55: 640-649
8. EAU guidelines address: http://www.uroweb.org/.
9. Seo SI, Jeon SS, Jo MK, Lee HM, Choi HY. Salvage high-intensity focused ultrasound (HIFU) therapy for locally - recurrent prostate cancer after primary HIFU or external beam radiotherapy (EBRT). Eur Urol Suppl 2008;7:119.
10. Chin JL, Touma N, Pautler SE, Guram KS, Bella AJ, Downey DB, et al. Serial histopathology results of salvage cryoablation for prostate cancer after radiation failure. J Urol 2003;170:1199-1202
11. Izawa JI, Morganstern N, Chan DM, Levy LB, Scott SM, Pisters LL. Incomplete glandular ablation after salvage cryotherapy for recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys 2003;56:468-472
12. Hancock SL, Cox RS, Bagshaw MA. Prostate specific antigen after radiotherapy for prostate cancer: a re-evaluation of long-term biochemical control and the kinetics of recurrence in patients treated at Stanford University. J Urol 1995;154: 1412-1417
13. Heidenreich A, Richter S, Thu D, Pfister D. Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy. Eur Urol 2010;57:437-443
14. Langenhuijsen JF, Eveline MP, Broers EWP, Vergunst H. Cryosurgery for prostate cancer: an update on clinical results of modern cryotechnology. Eur Urol 2009;55:76-86.
15. Berg A, Berner AA, Lilleby W, Bruland øS, Fossa SD, Nesland JM, et al. Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy. Int J Cancer 2007;120:1603-1609